Xeris Biopharma Holdings, Inc. (XERS)
6.68
+0.10
(+1.52%)
USD |
NASDAQ |
Feb 24, 16:00
6.61
-0.07
(-1.05%)
After-Hours: 20:00
Xeris Biopharma Holdings Shareholders Equity (Quarterly) : -0.861M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 370.19M |
| Total Liabilities (Quarterly) | 371.05M |
| Debt to Equity Ratio | -299.25 |
| Current Ratio | 1.928 |
| Net Debt Paydown Yield | 0.18% |